NASDAQ:BTCY Biotricity Q4 2025 Earnings Report $0.07 +0.00 (+0.43%) As of 09/25/2026 03:32 PM Eastern ProfileEarnings History Biotricity EPS ResultsActual EPS-$0.06Consensus EPS N/ABeat/MissN/AOne Year Ago EPSN/ABiotricity Revenue ResultsActual Revenue$3.70 millionExpected RevenueN/ABeat/MissN/AYoY Revenue GrowthN/ABiotricity Announcement DetailsQuarterQ4 2025Date7/15/2025TimeAfter Market ClosesConference Call DateTuesday, July 15, 2025Conference Call Time9:30AM ETUpcoming EarningsBiotricity's Q2 2027 earnings is estimated for Thursday, November 12, 2026, based on past reporting schedules, with a conference call scheduled on Friday, November 13, 2026 at 4:00 PM ET. Check back for transcripts, audio, and key financial metrics as they become available.Conference Call ResourcesAnnual Report (10-K)Earnings HistoryCompany ProfilePowered by Earnings DocumentsAnnual report(10-K) Biotricity Earnings HeadlinesBiotricity Q3 2026 Earnings Call: Complete TranscriptFebruary 14, 2026 | benzinga.comBiotricity, Inc. (OTC:BTCY) Q3 2026 earnings call transcriptFebruary 12, 2026 | msn.comYour book attachedBill Poulos is giving away his 'Safe Trade Options Formula' book for free - but only for a limited time through a temporary download link. He plans to charge for it soon. Download your copy now and lock it in at no cost, regardless of future pricing.September 26 at 1:00 AM | Profits Run (Ad)Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...February 12, 2026 | finance.yahoo.comBiotricity, Inc. (BTCY) Q3 2026 Earnings Call TranscriptFebruary 11, 2026 | seekingalpha.comBiotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDAFebruary 11, 2026 | globenewswire.comSee More Biotricity Headlines Get Earnings Announcements in your inboxWant to stay updated on the latest earnings announcements and upcoming reports for companies like Biotricity? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Biotricity and other key companies, straight to your email. Email Address About BiotricityBiotricity (NASDAQ:BTCY) (NASDAQ: BTCY) is a medical technology company focused on remote cardiac monitoring and digital health solutions. The company develops connected medical devices, software and cloud-based platforms designed to help physicians collect, review and manage cardiac data outside traditional clinical settings. Biotricity’s product portfolio has included Bioflux, an FDA-cleared mobile cardiac telemetry system for continuous electrocardiogram monitoring, as well as wearable and at-home cardiac monitoring technologies. Its solutions are intended to support the detection and management of arrhythmias and other heart-related conditions while improving communication between patients and healthcare providers. Founded in 2013 and headquartered in Redwood City, California, Biotricity primarily serves the U.S. healthcare market through relationships with medical practices, healthcare providers and patients. The company was founded and is led by Waqaas Al-Siddiq, who serves as chief executive officer.View Biotricity ProfileRead more More Earnings Resources from MarketBeat Earnings Tools Today's Earnings Tomorrow's Earnings Next Week's Earnings Upcoming Earnings Calls Earnings Newsletter Earnings Call Transcripts Earnings Beats & Misses Corporate Guidance Earnings Screener Latest Articles MarketBeat Week in Review – 09/21 - 09/25Costco Ends Its Fiscal Year on a High Note, Eyes Big ExpansionCracker Barrel Stock Is Rallying Again, But the Turnaround Still Has a Traffic ProblemDarden Restaurants Serves Up Fresh Catalysts for a Stock Price RallySoFi Is Bypassing the Banking Bottleneck With Stablecoin SettlementSuper Micro’s Vera Rubin Shipments Put Its AI Infrastructure Advantage to the TestHims & Hers Slides Nearly 7% as Legal Pressure Adds to Its Growing List of Risks Upcoming Earnings Micron Technology (9/30/2026)NIKE (10/1/2026)Accenture (10/1/2026)PepsiCo (10/8/2026)Delta Air Lines (10/9/2026)America Movil (10/13/2026)BlackRock (10/13/2026)Citigroup (10/13/2026)The Goldman Sachs Group (10/13/2026)JPMorgan Chase & Co. (10/13/2026) Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
